1.
Mallmann Q. The Tension Between “Brand-Name” Drugs And “Generics”: The Pharmaceutical Industry’s Temporary Monopoly And The Public Domain – The Legal Regime For Invention Patents. PIDCC. 2026;15(1):e20261501005. doi:10.16928/e20261501005